Glass Health is a clinical AI platform for clinicians that pairs ambient scribing with evidence-grounded decision support, drawing on peer-reviewed literature, clinical guidelines, and FDA drug labels. It is aimed at MDs, NPs, PAs, PharmDs, and DDSs across specialties and settings, and at healthcare organizations that want to embed clinical intelligence into their own products.
Glass listens in the background during an encounter, drafts the note, and surfaces clinical intelligence while the visit is still underway. The goal is to let clinicians keep eye contact with patients instead of turning to documentation. The platform supports 62+ languages for ambient scribing, which matters for multilingual care teams. Real-time insights can include differential considerations, follow-up questions, and next steps, so the note and the reasoning develop together rather than after the fact.
Every answer cites the sources it reasoned from. Glass draws on 38M+ peer-reviewed citations, current clinical guidelines, and 150,000+ FDA drug labels, and it presents those citations so clinicians can verify the evidence before acting. The company describes the system as an agentic clinical agent that analyzes the full clinical context and thousands of data points across the longitudinal record. In practice, that means the tool is designed less as a lookup engine and more as a reasoning partner for hard clinical questions.
Glass points to the Harvard-Stanford ARISE NOHARM evaluation, a physician-validated clinical safety benchmark, where it ranked among the top medical AI systems, ahead of models from OpenAI and Anthropic. The company also publishes an internal model scorecard covering nine benchmarks, including ACI-Bench, MedHallu, MMLU-Med, MedQA, AMEGA, JAMA CCS, NEJM CPCs, PubMedQA, and MedXpertQA. In that scorecard, Glass 5.5 Deep Reasoning reports an overall score of 88.7%, compared with 81.4% for GPT-5.4 and 78% for Opus 4.5. These are internal evaluations against external datasets using identical prompts, so they are best read as one signal among several rather than a final verdict on clinical performance.
Glass connects with Epic, eClinicalWorks, athenahealth, and Elation through SMART on FHIR, with patient context flowing directly into the platform to reduce copy-pasting and context switching. The company runs an assisted implementation from kickoff to go-live, and the platform works fully without an EHR connection from day one. That flexibility matters for practices that are not ready to integrate or that use an EHR outside the supported list.
Glass runs on HIPAA-compliant infrastructure and offers BAAs for providers and organizations, with safeguards for protected health information. The company reports 120,000+ clinicians on the platform across 170+ countries and says its work has impacted 1,500,000+ lives. It is backed by investors including Y Combinator, Initialized Capital, and Breyer Capital. For a clinical tool, those operational details are part of the product, not a footnote.
Glass offers a free, ad-supported Lite plan for students, then paid tiers for trainees and professionals. Starter is $20 per month, Pro is $90 per month, and Max is $200 per month. Higher tiers add extended or maximum scribing and decision support, advanced or premium models, customization, and ad-free access. EHR integration is listed on the Max plan. Patient pricing is handled separately through Glass for Patients.